Phantom Neuro: Funding, Investors & Team (Sep 2026)
Phantom Neuro specializes in developing cutting-edge muscle-machine interfaces to improve robotic limb rehabilitation. By integrating neurotechnology with robotic systems, the company aims to enhance user mobility with a focus on natural movement and improving overall user experience. Through its minimally invasive approach, Phantom Neuro seeks to provide precise control of robotic limbs for better rehabilitation outcomes. The company is dedicated to advancing neurotechnology and providing valuable tools for rehabilitating individuals with mobility limitations. Additionally, Phantom Neuro explores different applications of its technologies to contribute to the overall field of assistive robotics.
Phantom Neuro has raised $19.0M across 1 funding round on record, the most recent a Series A of $19.0M announced in Apr 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Phantom Neuro Company Profile and Key Stats
Latest funding round on record: Apr 2025.
Phantom Neuro Funding Rounds
Phantom Neuro Founders and Leadership Team
Contact details for the Phantom Neuro team: 1 of 1 has an email address on file.
Start 14-day free trial →Phantom Neuro Funding Compared to Other Biotechnology Startups
Phantom Neuro's latest round of $19.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Phantom Neuro in Biotechnology and Austin
Companies Similar to Phantom Neuro
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Phantom Neuro Funding FAQs
What does Phantom Neuro do?
Phantom Neuro specializes in developing cutting-edge muscle-machine interfaces to improve robotic limb rehabilitation. By integrating neurotechnology with robotic systems, the company aims to enhance user mobility with a focus on natural movement and improving overall user experience. Through its minimally invasive approach, Phantom Neuro seeks to provide precise control of robotic limbs for better rehabilitation outcomes. The company is dedicated to advancing neurotechnology and providing valuable tools for rehabilitating individuals with mobility limitations. Additionally, Phantom Neuro explores different applications of its technologies to contribute to the overall field of assistive robotics.
How much funding has Phantom Neuro raised?
Phantom Neuro has raised $19.0M across 1 round on record. The most recent is a Series A of $19.0M announced in Apr 2025.
When did Phantom Neuro last raise funding?
Phantom Neuro's most recent funding round on record is a Series A of $19.0M, announced in Apr 2025.
Who founded Phantom Neuro?
FundedIQ lists Connor Glass (Founder) at Phantom Neuro.
Where is Phantom Neuro headquartered?
Phantom Neuro is based in Austin, Texas, United States.
How many employees does Phantom Neuro have?
Phantom Neuro is in the 11-50 employee band.
How does Phantom Neuro's funding compare to other Biotechnology startups?
Phantom Neuro's latest round of $19.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Phantom Neuro Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Phantom Neuro is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.